Lindy Gillian Durrant

Title: Lindy Gillian Durrant: Innovator in Cancer Research

Introduction

Lindy Gillian Durrant is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of cancer research through his innovative work and patented inventions. With a total of 3 patents, Durrant has focused on developing targeted treatments for cancer.

Latest Patents

Durrant's latest patents include "Sialyl-di-Lewisas expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto." This invention relates to an isolated specific binding member capable of binding sialyl-di-Lewis, along with associated treatments and pharmaceutical compositions for cancer treatment. Another significant patent is "Glycans as functional cancer targets and antibodies thereto," which describes a glycan structure attached to a lipid or protein backbone, along with isolated binding members capable of binding to it.

Career Highlights

Throughout his career, Durrant has worked with various institutions, including the University of Nottingham. His research has focused on the development of innovative cancer therapies, showcasing his commitment to advancing medical science.

Collaborations

Durrant has collaborated with notable colleagues, including Tina Parsons and Mireille Vankemmelbeke, who have contributed to his research endeavors.

Conclusion

Lindy Gillian Durrant's work in cancer research and his patented inventions highlight his dedication to improving treatment options for patients. His contributions continue to influence the field and inspire future innovations.